Details for Patent: 10,406,332

Which drugs does patent 10,406,332 protect, and when does it expire?

Patent 10,406,332 protects SINUVA and is included in one NDA.

This patent has thirteen patent family members in seven countries.

Summary for Patent: 10,406,332

Title:	Systems, devices, and method for treating a sinus condition
Abstract:	Systems, devices, and methods may be used for delivery of an implant to a bodily cavity. The implant may include a hub and a plurality of legs, and may be moveable between a low-profile and expanded configuration. The systems may include a crimping device having a crimping member with a plurality of arms. The plurality of arms may engage the plurality of legs of the implant, and may move the legs to move the implant to the low-profile configuration. In some instances a delivery device may aid in crimping and/or delivery of the implant.
Inventor(s):	Abbate; Anthony J. (Santa Clara, CA)
Assignee:	Intersect ENT, Inc. (Menlo Park, CA)
Application Number:	14/210,078
Patent Claim Types: see list of patent claims	Composition; Device;

Drugs Protected by US Patent 10,406,332

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Intersect Ent Inc	SINUVA	mometasone furoate	IMPLANT;IMPLANTATION	209310-001	Dec 8, 2017		RX	Yes	No			Y

International Family Members for US Patent 10,406,332

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014236729
Australia	2019201045
Canada	2903848